Splash Clinical’s Contribution to Global Ulcerative Colitis Trial

A global phase two ulcerative colitis clinical trial ran for ten months and supported 61 study sites across Canada, Germany, Poland, and the United States. The campaign used social media, patient advocacy groups, and Splash’s virtual waiting room (vWR) technology to allow potential participants to stay engaged while not experiencing active symptoms.